Iressa Versus Docetaxel (Taxotere)
Public ClinicalTrials.gov record NCT00076388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non-Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the effects of ZD1839 or docetaxel in patients with advanced non-small cell lung cancer (NSCLC) that has recurred or progressed after receiving prior treatment with platinum-based chemotherapy.
Study identification
- NCT ID
- NCT00076388
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,440 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2004
- Primary completion
- Feb 28, 2007
- Completion
- Sep 30, 2007
- Last update posted
- May 12, 2011
2004 – 2007
United States locations
- U.S. sites
- 35
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Fountain Valley | California | — | — |
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Santa Rosa | California | — | — |
| Research Site | Stockton | California | 95204 | — |
| Research Site | Colorado Springs | Colorado | — | — |
| Research Site | Norwich | Connecticut | — | — |
| Research Site | Newark | Delaware | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Macon | Georgia | — | — |
| Research Site | Tucker | Georgia | — | — |
| Research Site | Skokie | Illinois | 60077 | — |
| Research Site | Knoxville | Kentucky | — | — |
| Research Site | Saint Louis Park | Minnesota | — | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | Rochester | New York | 14621 | — |
| Research Site | Syracuse | New York | 13210 | — |
| Research Site | Chapel Hill | North Carolina | 27599 | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Cleveland | Ohio | 44195 | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Pittsburgh | Pennsylvania | — | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | 77030-4009 | — |
| Research Site | Tyler | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Fairfax | Virginia | — | — |
| Research Site | Seattle | Washington | — | — |
| Research Site | Racine | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00076388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 12, 2011 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00076388 live on ClinicalTrials.gov.